TECH · 10-Q/A · 2026Q3 · Full report

Market Demand Trends

BIO-TECHNE Corp · 2026-11-12 · Importance 49 · Surprise 32

Bio-Techne develops and sells biotechnology reagents, instruments, and services for research and clinical diagnostic markets worldwide. In the quarter ended September 30, 2026, consolidated organic revenue increased 7% year over year, with foreign currency having an immaterial impact and the business held for sale reducing reported growth by 2%. Protein Sciences organic revenue rose 9%, while Diagnostics and Spatial Biology organic revenue grew 1%, indicating stronger demand in Protein Sciences than in Diagnostics and Spatial Biology.

Key facts

• Bio-Techne identifies supply-chain challenges, reliance on internal manufacturing, currency fluctuations, and facility-construction or improvement delays and expenses as factors that could affect actual results. source